BINEX Co., Ltd. (KOSDAQ:053030)
South Korea · Delayed Price · Currency is KRW 16,120
+60 (0.37%)
Oct 10, 2025, 3:30 PM KST
BINEX Market Cap
BINEX has a market cap or net worth of 513.38 billion as of October 10, 2025. Its market cap has decreased by -21.51% in one year.
Market Cap
513.38B
Enterprise Value
584.11B
Revenue
153.18B
Ranking
n/a
PE Ratio
n/a
Stock Price
16,120.00
Market Cap Chart
Since March 1, 2002, BINEX's market cap has increased from 25.29B to 513.38B, an increase of 1,930.31%. That is a compound annual growth rate of 13.60%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 2, 2025 | 511.47B | -12.43% |
| Dec 30, 2024 | 584.09B | 111.03% |
| Dec 28, 2023 | 276.77B | -22.51% |
| Dec 29, 2022 | 357.18B | -24.01% |
| Dec 30, 2021 | 470.05B | -43.25% |
| Dec 30, 2020 | 828.30B | 236.18% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 72.17T |
| Celltrion | 38.24T |
| ALTEOGEN | 24.66T |
| Yuhan | 9,028.52B |
| SK Biopharmaceuticals | 8,136.75B |
| Peptron | 6,866.96B |
| PharmaResearch | 5,631.19B |
| LigaChem Biosciences | 5,483.63B |